Su-Yang Liu

Title: Innovations of Su-Yang Liu in Antiviral Therapy

Introduction

Su-Yang Liu is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of antiviral therapy, particularly through his innovative research at the University of California. His work focuses on methods to inhibit viral growth and infectivity, showcasing his dedication to advancing medical science.

Latest Patents

Su-Yang Liu holds a patent for a broad antiviral therapy utilizing membrane-modifying oxysterols. This invention, titled "Broad antiviral therapy with membrane modifying oxysterols," relates to a method for inhibiting the growth and/or proliferation and/or infectivity of viruses in mammalian cells. The method involves administering 25-hydroxycholesterol (25HC) in amounts sufficient to inhibit viral activity. This approach can be applied both in vivo and in vitro, targeting various viruses such as VSV, HSV, MHV68, HCV, HIV, EBOV, RVFV, RSSEV, and Nipah virus. In one embodiment, the 25HC is administered topically to mucosal surfaces.

Career Highlights

Throughout his career, Su-Yang Liu has demonstrated a strong commitment to research and innovation. His work has led to the development of effective antiviral strategies, contributing to the broader understanding of viral infections and potential treatments. With a patent portfolio that includes 1 patent, he continues to push the boundaries of scientific knowledge.

Collaborations

Su-Yang Liu collaborates with Genhong Cheng, a fellow researcher who brings valuable expertise to their joint efforts in antiviral research. Their partnership exemplifies the importance of collaboration in advancing scientific discoveries.

Conclusion

Su-Yang Liu's innovative work in antiviral therapy highlights the potential for new treatments in combating viral infections. His contributions to the field are significant and reflect a commitment to improving public health through scientific research.